AI-generated conceptual illustration; not a photograph of Hamade Eye Care Clinic or its equipment.

Laser vision correction reshapes the cornea so that light focuses more accurately on the retina. For suitable patients, it can reduce dependence on glasses or contact lenses. The choice between LASIK, PRK, and SMILE depends on the prescription, the structure and health of the eyes, and personal priorities. A modern device is one part of the decision; careful screening and realistic expectations remain essential. FDA overview

How the procedures differ

LASIK involves creating a thin corneal flap, lifting it, and using an excimer laser to reshape the tissue underneath. The flap is then repositioned. A femtosecond laser can create the flap. Vision often recovers relatively quickly, but the flap introduces its own possible complications. FDA procedure guide

PRK reshapes the corneal surface after the outer cell layer is removed. It avoids a LASIK flap, which may be helpful for selected people whose work or sports involve an eye-injury risk. The surface needs time to regrow, so early discomfort and a slower visual recovery are expected. Corneal haze is another risk to discuss. A thin or irregular cornea still requires careful assessment; PRK is not automatically safe when LASIK is unsuitable. AAO PRK guidance

SMILE, or small-incision lenticule extraction, uses a femtosecond laser to create a small disc of tissue inside the cornea. The surgeon removes it through a small opening, without creating a LASIK flap. Eligible prescriptions depend on the device and country. For example, U.S. VisuMax labeling covers specified ranges of myopia with or without astigmatism in patients aged 22 or older with stable refraction. FDA SMILE information, FDA indication details

What makes someone a suitable candidate?

A consultation should assess more than the glasses prescription. Corneal shape and thickness, tear-film health, eye pressure, and the wider health of the eye all matter. A stable prescription is important. Pregnancy, breastfeeding, some medical conditions, and certain medicines may affect timing or suitability. FDA screening guidance

Keratoconus or suspicious corneal measurements can make tissue-removing laser surgery unsafe because of the risk of progressive corneal weakening, called ectasia. Severe dry eye also requires particular caution. A responsible recommendation may be to treat an eye-surface problem first, wait for stability, or continue with glasses or contact lenses. FDA contraindications

What has improved in personalized planning?

Topography-guided LASIK uses detailed corneal-surface measurements, while wavefront-guided LASIK incorporates measurements of the eye's optical imperfections. These approaches aim to tailor treatment more closely to the eye. Lu and Manche, 2025

A 2026 randomized study compared the two approaches in opposite eyes of 66 participants. Both produced good six-month outcomes, with different advantages on certain measurements and similar dry-eye symptoms. This small, short-term comparison does not identify one method as best for every patient. Ask why a particular planning approach is appropriate for your eyes and which alternatives were considered. Dudenhoefer and colleagues, 2026

Benefits and side effects can coexist

The FDA's PROWL studies found that more than 95% of participants were satisfied with their vision after LASIK. However, among participants without visual symptoms before surgery, up to 46% reported at least one new visual symptom at three months. Less than 1% reported major difficulty with usual activities because of any single visual symptom. These findings show why satisfaction, symptoms, and day-to-day function should all be discussed. They are study results, not a prediction for an individual patient. FDA PROWL findings, original PROWL research

Potential problems include dry eye, glare, halos, residual prescription, and needing further correction. Some symptoms persist. Infection, scarring, ectasia, and loss of best-corrected vision are less common but important risks. Surgery also does not stop age-related loss of near focusing, so reading glasses may still become necessary. FDA risk information, AAO clinical guidance

Questions worth taking to the consultation

  • What do my corneal scans and tear-film assessment show?
  • Why does this procedure fit my prescription and daily activities?
  • How long should I allow before driving, work, or sport?
  • What happens if I have persistent symptoms or a remaining prescription?

Follow the prescribed drop schedule and attend postoperative checks. Contact the surgical team promptly for severe pain, worsening vision, or unexpected symptoms. Recovery varies, so return-to-driving advice should be individualized. FDA aftercare guidance

A refractive consultation is an opportunity to review these choices and decide whether an operation offers an acceptable balance of benefit and risk for you.

Related reading

Myopia | Astigmatism | Dry eye

This article is for general education and does not replace an examination, diagnosis, or treatment plan from your ophthalmologist. The options described may not be suitable or available for every patient.

Sources

  1. U.S. Food and Drug Administration. LASIK (Accessed 2026-10-05).
  2. U.S. Food and Drug Administration. What should I expect before, during, and after surgery? (Accessed 2026-10-05).
  3. American Academy of Ophthalmology / EyeWiki. Photorefractive Keratectomy (Accessed 2026-10-05).
  4. U.S. Food and Drug Administration. VisuMax Femtosecond Laser: Summary of Safety and Effectiveness Data, PMA P150040 (2016).
  5. U.S. Food and Drug Administration. VisuMax Femtosecond Laser: Summary of Safety and Effectiveness Data, PMA P150040/S003 (2018).
  6. U.S. Food and Drug Administration. When is LASIK not for me? (Accessed 2026-10-05).
  7. Dudenhoefer NE, Rodgers SB, Evangelista CB, Legault GL, Chen SS, Kohler PD, Capo-Aponte JE. Comparison of clinical and patient-reported outcomes of contralateral topography-guided vs wavefront-guided LASIK (2026-07-01).
  8. U.S. Food and Drug Administration. LASIK Quality of Life Collaboration Project (Accessed 2026-10-05).
  9. U.S. Food and Drug Administration. What are the risks and how can I find the right doctor for me? (Accessed 2026-10-05).
  10. Lu L, Manche E. Prospective, randomized, contralateral eye comparison of wavefront-guided and topography-guided LASIK (2025).
  11. Eydelman M, Hilmantel G, Tarver ME, et al.. Symptoms and Satisfaction of Patients in the Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL) Studies (2017).
  12. Jacobs DS, Lee JK, Shen TT, et al.. Refractive Surgery Preferred Practice Pattern (2023).

Evidence checked: 5 October 2026.